IE44095B1 - Pleuromutilin derivatives and their use - Google Patents
Pleuromutilin derivatives and their useInfo
- Publication number
- IE44095B1 IE44095B1 IE794/76A IE79476A IE44095B1 IE 44095 B1 IE44095 B1 IE 44095B1 IE 794/76 A IE794/76 A IE 794/76A IE 79476 A IE79476 A IE 79476A IE 44095 B1 IE44095 B1 IE 44095B1
- Authority
- IE
- Ireland
- Prior art keywords
- swine
- accordance
- compound
- pigs
- administered
- Prior art date
Links
- ZRZNJUXESFHSIO-VYTKZBNOSA-N pleuromutilin Chemical class C([C@H]([C@]1(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]2C)OC(=O)CO)C)C[C@]32[C@H]1C(=O)CC3 ZRZNJUXESFHSIO-VYTKZBNOSA-N 0.000 title 1
- 241000282898 Sus scrofa Species 0.000 claims description 54
- 208000001848 dysentery Diseases 0.000 claims description 20
- 150000001875 compounds Chemical class 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 15
- 230000037396 body weight Effects 0.000 claims description 9
- 241001465754 Metazoa Species 0.000 claims description 8
- 239000004480 active ingredient Substances 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- 239000003651 drinking water Substances 0.000 claims description 7
- 235000020188 drinking water Nutrition 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 5
- 238000002347 injection Methods 0.000 claims description 2
- 239000007924 injection Substances 0.000 claims description 2
- -1 methyl-6-vinyl-3a, 9-propano3aH-cyclo penta cyclo octen-1(4H)-one Chemical compound 0.000 claims 2
- 241000282887 Suidae Species 0.000 description 40
- 239000007858 starting material Substances 0.000 description 20
- 239000000203 mixture Substances 0.000 description 13
- 229940088594 vitamin Drugs 0.000 description 13
- 229930003231 vitamin Natural products 0.000 description 13
- 235000013343 vitamin Nutrition 0.000 description 13
- 239000011782 vitamin Substances 0.000 description 13
- 208000015181 infectious disease Diseases 0.000 description 11
- 241000589893 Brachyspira hyodysenteriae Species 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 229910052500 inorganic mineral Inorganic materials 0.000 description 9
- 239000011707 mineral Substances 0.000 description 9
- 235000010755 mineral Nutrition 0.000 description 9
- 150000003722 vitamin derivatives Chemical class 0.000 description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 8
- OBUUFWIMEGVAQS-UHFFFAOYSA-N Pleuromutenol Natural products CC1C(O)C(C)(C=C)CC(O)C2(C)C(C)CCC31C2C(=O)CC3 OBUUFWIMEGVAQS-UHFFFAOYSA-N 0.000 description 8
- 235000012054 meals Nutrition 0.000 description 8
- STZYTFJPGGDRJD-NHUWBDDWSA-N retapamulin Chemical compound C([C@H]([C@@]1(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]2C)OC(=O)CS[C@@H]3C[C@H]4CC[C@H](N4C)C3)C)C[C@]32[C@H]1C(=O)CC3 STZYTFJPGGDRJD-NHUWBDDWSA-N 0.000 description 8
- 229960002771 retapamulin Drugs 0.000 description 8
- 241000589886 Treponema Species 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 230000000112 colonic effect Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 6
- 241000589970 Spirochaetales Species 0.000 description 5
- VZCYOOQTPOCHFL-OWOJBTEDSA-M fumarate(1-) Chemical compound OC(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-M 0.000 description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 4
- 241000273930 Brevoortia tyrannus Species 0.000 description 4
- 244000068988 Glycine max Species 0.000 description 4
- 235000010469 Glycine max Nutrition 0.000 description 4
- 241000209140 Triticum Species 0.000 description 4
- 235000021307 Triticum Nutrition 0.000 description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 4
- 229930003316 Vitamin D Natural products 0.000 description 4
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 4
- 239000005862 Whey Substances 0.000 description 4
- 102000007544 Whey Proteins Human genes 0.000 description 4
- 108010046377 Whey Proteins Proteins 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 229910000389 calcium phosphate Inorganic materials 0.000 description 4
- 239000001506 calcium phosphate Substances 0.000 description 4
- 235000011010 calcium phosphates Nutrition 0.000 description 4
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 4
- 229960001231 choline Drugs 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 235000013379 molasses Nutrition 0.000 description 4
- 229940105680 niacin 20 mg Drugs 0.000 description 4
- 229940023136 pantothenic acid 10 mg Drugs 0.000 description 4
- 229940088197 riboflavin 3 mg Drugs 0.000 description 4
- 238000007790 scraping Methods 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 4
- 235000019155 vitamin A Nutrition 0.000 description 4
- 239000011719 vitamin A Substances 0.000 description 4
- 235000019166 vitamin D Nutrition 0.000 description 4
- 239000011710 vitamin D Substances 0.000 description 4
- 150000003710 vitamin D derivatives Chemical class 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- 229940045997 vitamin a Drugs 0.000 description 4
- 229940046008 vitamin d Drugs 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 3
- 208000021017 Weight Gain Diseases 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- 229910052740 iodine Inorganic materials 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 229910052748 manganese Inorganic materials 0.000 description 3
- 239000011572 manganese Substances 0.000 description 3
- 235000019786 weight gain Nutrition 0.000 description 3
- 230000004584 weight gain Effects 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 101100184148 Xenopus laevis mix-a gene Proteins 0.000 description 2
- 235000021052 average daily weight gain Nutrition 0.000 description 2
- 239000013256 coordination polymer Substances 0.000 description 2
- 235000021051 daily weight gain Nutrition 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical group CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- 101100334117 Caenorhabditis elegans fah-1 gene Proteins 0.000 description 1
- 241000589877 Campylobacter coli Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010012741 Diarrhoea haemorrhagic Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 101100345673 Xenopus laevis mix-b gene Proteins 0.000 description 1
- YOPYBZFTJOLXLJ-UHFFFAOYSA-N [I].[Zn].[Mn].[Fe].[Cu] Chemical compound [I].[Zn].[Mn].[Fe].[Cu] YOPYBZFTJOLXLJ-UHFFFAOYSA-N 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 208000027909 hemorrhagic diarrhea Diseases 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000000677 immunologic agent Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- SMJRBWINMFUUDS-UHFFFAOYSA-M thien-2-ylacetate Chemical compound [O-]C(=O)CC1=CC=CS1 SMJRBWINMFUUDS-UHFFFAOYSA-M 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Fodder In General (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Feed For Specific Animals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/576,911 US3987194A (en) | 1975-05-12 | 1975-05-12 | Use of pleuromutilin derivatives for the treatment of swine dysentery |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE44095L IE44095L (en) | 1976-11-12 |
| IE44095B1 true IE44095B1 (en) | 1981-08-12 |
Family
ID=24306516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE794/76A IE44095B1 (en) | 1975-05-12 | 1976-04-13 | Pleuromutilin derivatives and their use |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US3987194A (OSRAM) |
| AU (1) | AU497468B2 (OSRAM) |
| DE (1) | DE2621091C2 (OSRAM) |
| FR (1) | FR2310751A1 (OSRAM) |
| GB (1) | GB1543179A (OSRAM) |
| IE (1) | IE44095B1 (OSRAM) |
| IT (1) | IT1061257B (OSRAM) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2072012B (en) * | 1980-03-14 | 1984-07-25 | Squibb & Sons Inc | Veterinary compositions containing pleuromutilin derivatives |
| BE902010A (fr) * | 1984-03-28 | 1985-09-25 | Hajdusagi Agraripari Egyesules | Nouvelles combinaisons de medicaments ayant un effet synergique et procede pour les preparer. |
| AT400674B (de) * | 1991-07-24 | 1996-02-26 | Biochemie Gmbh | Pharmazeutische pleuromutilin-zubereitung |
| UY25225A1 (es) | 1997-10-29 | 2000-12-29 | Smithkline Beecham Plc | Derivados de pleuromutilina utiles como agentes antimicrobianos |
| CO5390081A1 (es) * | 2001-11-28 | 2004-04-30 | Novartis Ag | Compuestos organicos |
| GB0308114D0 (en) * | 2003-04-08 | 2003-05-14 | Glaxo Group Ltd | Novel compounds |
| GB0513058D0 (en) * | 2005-06-27 | 2005-08-03 | Sandoz Ag | Organic compounds |
| AU2013353723B2 (en) | 2012-12-03 | 2018-02-22 | Pfizer Inc. | Novel selective androgen receptor modulators |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE789629A (fr) * | 1971-10-05 | 1973-04-03 | Sandoz Sa | Nouveaux derives de la pleuromutiline, leur preparation et leurapplication en therapeutique |
-
1975
- 1975-05-12 US US05/576,911 patent/US3987194A/en not_active Expired - Lifetime
-
1976
- 1976-04-13 IE IE794/76A patent/IE44095B1/en unknown
- 1976-04-13 GB GB15109/76A patent/GB1543179A/en not_active Expired
- 1976-04-20 AU AU13122/76A patent/AU497468B2/en not_active Expired
- 1976-05-06 IT IT49360/76A patent/IT1061257B/it active
- 1976-05-11 FR FR7614124A patent/FR2310751A1/fr active Granted
- 1976-05-12 DE DE2621091A patent/DE2621091C2/de not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR2310751B1 (OSRAM) | 1979-09-21 |
| FR2310751A1 (fr) | 1976-12-10 |
| DE2621091C2 (de) | 1986-02-20 |
| AU1312276A (en) | 1977-10-27 |
| US3987194A (en) | 1976-10-19 |
| IE44095L (en) | 1976-11-12 |
| GB1543179A (en) | 1979-03-28 |
| DE2621091A1 (de) | 1976-11-25 |
| AU497468B2 (en) | 1978-12-14 |
| IT1061257B (it) | 1983-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5876780A (en) | Compositions for treating coccidiosis | |
| CA2455595C (en) | Compositions of yeast cell walls and mannanoligosaccharides for control of coccidiosis | |
| US5834473A (en) | Method for treating coccidiosis | |
| IE44095B1 (en) | Pleuromutilin derivatives and their use | |
| Björk et al. | Effects of amperozide on biting behavior and performance in restricted-fed pigs following regrouping | |
| EP0910363B1 (en) | Veterinary use of a pleuromutilin derivative | |
| KIMURA et al. | An application of dried bifidobacteria preparation to scouring animals | |
| AU682354B2 (en) | Compositions for administration to animals with coccidiosis | |
| US4061732A (en) | Control of lactic acidosis in ruminants | |
| US4005211A (en) | Lactation stimulation employing pimozide | |
| RU2174833C1 (ru) | Препарат для профилактики и лечения кокцидиоза птиц | |
| US4659713A (en) | Quinoxalinedione compounds useful for controlling coccidiosis | |
| US4041175A (en) | Use of pleuromutilin for the treatment of swine dysentery | |
| US3702362A (en) | Use of ureido diphenyl sulfones in the treatment of marek's disease | |
| Miller et al. | 142 Evaluation of dietary fiber in health challenged nursery pigs | |
| CN107279535A (zh) | 一种用于新生仔猪驱虫的饲料添加剂及生产方法 | |
| Carpenter et al. | Swine dysentery: Treatment with 4-nitro and 3-nitro-4-hydroxy phenyl arsonic acids and antibiotics | |
| US3185573A (en) | Animal feed composition and method of using same | |
| WO2025141424A1 (en) | Use of p-aminobenzoic acid compounds in the preparation of medicaments for treating coccidiosis in animals | |
| EP1210950B1 (en) | Composition against Coccidiosis | |
| US3786147A (en) | Method of controlling poultry coccidiosis | |
| US2797182A (en) | Cadmium anthranilate containing anthelmintics | |
| US3816630A (en) | Treatment of swine dysentery | |
| US3497594A (en) | Combinations of quinoxaline-di-n-oxides and tetracycline antibiotics | |
| US3961068A (en) | Use of ipronidazole in combatting Sphaerophorus necrophorus infections |